Nanshan S. Zhong
Experienced in Emphysema

Nanshan S. Zhong

Bio Island, 
Guangzhou, CN 
Experienced in Emphysema
Bio Island, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Nanshan Zhong practices in Guangzhou, China. Mr. Zhong is rated as an Experienced expert by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Allergic Rhinitis, Adenoidectomy, and Endoscopy.

His clinical research consists of co-authoring 471 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Emphysema.

Gender
Male

Locations

Bio Island, Guangzhou, 510320, China
Other Locations
151 Yanjiang Rd, Guangzhou, 510120, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Diagnostic and Monitoring Significance of Circulating Tumor DNA (ctDNA) Methylation Analysis by Next-Generation Sequencing in Benign and Malignant Pulmonary Nodules
Diagnostic and Monitoring Significance of Circulating Tumor DNA (ctDNA) Methylation Analysis by Next-Generation Sequencing in Benign and Malignant Pulmonary Nodules
Enrollment Status: Unknown
Publish Date: May 24, 2023
Intervention Type: Diagnostic test
A Phase 2 Study to Evaluate the Safety and Efficacy of Human Monoclonal Antibodies, BRII-196 and BRII-198, Administered by Intravenous Infusion for the Treatment of COVID-19 Patients
A Phase 2 Study to Evaluate the Safety and Efficacy of Human Monoclonal Antibodies, BRII-196 and BRII-198, Administered by Intravenous Infusion for the Treatment of COVID-19 Patients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

471 Total Publications

Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study
Efficacy and clinical remission in patients with severe asthma and blood eosinophil counts ≥150 cells/μl treated with benralizumab: a sub-analysis of the Phase 3 MIRACLE study
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zhong's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 54 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile